Federation des caisses Desjardins du Quebec’s Harvard Bioscience HBIO Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,614	Closed	-$36.1K	–	2172
2020 Q1	$36.1K	Hold	1,614	–	–	﹤0.01%	1343
2019 Q4	$49.2K	Hold	1,614	–	–	﹤0.01%	1523
2019 Q3	$49.6K	Hold	1,614	–	–	﹤0.01%	1477
2019 Q2	$32.2K	Hold	1,614	–	–	﹤0.01%	1595
2019 Q1	$69.6K	Hold	1,614	–	–	﹤0.01%	1236
2018 Q4	$51.4K	Hold	1,614	–	–	﹤0.01%	1276
2018 Q3	$84.8K	Hold	1,614	–	–	﹤0.01%	1219
2018 Q2	$86.5K	Hold	1,614	–	–	﹤0.01%	1221
2018 Q1	$80.7K	Hold	1,614	–	–	﹤0.01%	1217
2017 Q4	$53.1K	Hold	1,614	–	–	﹤0.01%	1323
2017 Q3	$60.7K	Hold	1,614	–	–	﹤0.01%	1271
2017 Q2	$41.2K	Hold	1,614	–	–	﹤0.01%	1418
2017 Q1	$42K	Buy	+1,614	New	+$46.5K	﹤0.01%	1168

Other funds holding HBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's HBIO Position: Q2 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Harvard Bioscience (HBIO) in Q2 2020, closing a stake of 1,614 shares — an estimated $36.1K sold.

Federation des caisses Desjardins du Quebec first reported a position in HBIO in Q1 2017 and held it in 13 quarters. The position peaked at $86.5K in Q2 2018. 87 funds tracked by Wall St. Rank hold HBIO as of Q2 2020.

Federation des caisses Desjardins du Quebec reported no remaining Harvard Bioscience position as of Q2 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1,614 Harvard Bioscience shares in Q2 2020, an estimated $36.1K.
Federation des caisses Desjardins du Quebec first reported a position in Harvard Bioscience in Q1 2017 and held it in 13 quarters.
Federation des caisses Desjardins du Quebec's Harvard Bioscience position peaked at $86.5K in Q2 2018.
87 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2020, filed 30 Aug 2024.